FIELD: medicine.
SUBSTANCE: invention relates to medicine, in particular to diagnosing cardiovascular diseases, namely, to laboratory diagnostic methods for predisposition to development of coronary restenosis in the place of drug-eluting stents in patients with stable exertional angina following planned coronary stenting (CS). Method for prediction of restenosis development in patients with stable exertional angina following coronary stenting involves blood examination of patients, biochemical blood analysis, high-sensitivity C-reactive protein (hsCRP) content is determined by nephelometric method before coronary stenting and 1 month after intervention, and concentration difference of said index ≥0.9 mg/l (≥25 %) testifies to high risk of restenosis development.
EFFECT: technical result consists in improvement of the method and detection of an additional predictor of restenosis development, available for wide use.
1 cl, 1 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DIAGNOSIS OF CORONARY ARTERY STENOSIS RESTENOSIS IN PATIENTS WITH CORONARY HEART DISEASE WITH CHRONIC HEART FAILURE | 2017 |
|
RU2649131C1 |
| METHOD OF PREDICTING RISK OF DEVELOPMENT OF ADVERSE CARDIOVASCULAR EVENTS IN PATIENTS WITH CORONARY HEART DISEASE AND TYPE 2 DIABETES WITH PRIOR CORONARY ARTERY STENTING | 2015 |
|
RU2582291C1 |
| METHOD OF ESTIMATING RISK OF DEVELOPMENT OF UNFAVOURABLE CARDIOVASCULAR EVENTS IN PATIENTS WITH ISCHEMIC HEART DISEASE SUBJECTED TO ENDOVASCULAR MYOCARDIUM REVASCULARISATION DURING ONE YEAR AFTER INTERFERENCE | 2010 |
|
RU2444297C1 |
| METHOD OF STENT RESTENOSIS FORECAST IN CORONARY ARTERIES AT EARLY STAGES AFTER ENDOVASCULAR MYOCARDIAL REVASCULARISATION | 2007 |
|
RU2349919C1 |
| METHOD FOR IMMUNOLOGICAL PREDICTION OF SMALL MYOCARDIAL DAMAGE | 2014 |
|
RU2585391C1 |
| METHODS FOR DETERMINATION OF INDICATIONS FOR SINGLE-DAY HOSPITALIZATION FOR X-RAY ENDOVASCULAR TREATMENT OF CORONARY ARTERIES AND TO PATIENT DISCHARGE NEXT DAY AFTER OPERATION | 2017 |
|
RU2644930C1 |
| METHOD FOR PREDICTING RISK OF DEVELOPING CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH STABLE ISCHEMIC HEART DISEASE, HAVING UNDERGONE PLANNED ENDOVASCULAR MYOCARDIAL REVASCULARIZATION | 2021 |
|
RU2770273C1 |
| METHOD FOR PREDICTION OF RISK OF DEVELOPING CORONARY ARTERY RESTENOSIS AFTER STENTING PROCEDURE IN PATIENTS WITH ISCHEMIC HEART DISEASE | 2013 |
|
RU2523391C1 |
| METHOD FOR DIAGNOSING CORONARY ARTERIES RESTENOSIS CASES AFTER ENDOVASCULAR MYOCARDIUM REVASCULARIZATION | 2005 |
|
RU2308884C2 |
| DIAGNOSTIC TECHNIQUE FOR PREDISPOSITION TO ATHEROSCLEROSIS PROGRESSION IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE AS SHOWN BY PERIPHERAL BLOOD INTERLEUKIN-10 AND INTERLEUKIN-17 CONCENTRATIONS | 2014 |
|
RU2566288C1 |
